OBJECTIVE: To assess clinicians' use of shared decision making (SDM) skills, enabling patient treatment evaluations (appraisals); and varieties of patient appraisals and clinicians' preceding and following utterances. METHODS: Two coders rated videotaped initial visits of 25 early-stage prostate cancer patients to their radiation oncologist. SDM skills were assessed using the Decision Analysis System for Oncology (DAS-O); appraisals and clinicians' utterances were labeled using qualitative methodology. RESULTS: Clinicians offered a treatment choice to 10 patients. They informed 15/25 about pros and 20/25 about cons of options. Patients expressed 67 appraisals (median/visit=2; range, 0-12). Half of appraisals were favorable and one-fourth was unfavorable toward treatment options. One-fifth referred to explicit tradeoffs. One-third of appraisals followed clinician requests; 58% followed clinician information. Clinicians approved almost half of appraisals. They contested, ignored or highlighted a minority. CONCLUSION: Clinicians infrequently offered patients a choice or explored appraisals. Most appraisals supported rather than challenged treatment options. Clinicians most often legitimized appraisals, thereby helping patients to feel good about the decision. Exploring appraisals may help patients in forming more stable preferences, thus benefiting patients in the long run. PRACTICE IMPLICATION: Clinicians should request patient appraisals and ascertain whether these seem well-informed before making treatment recommendations.
OBJECTIVE: To assess clinicians' use of shared decision making (SDM) skills, enabling patient treatment evaluations (appraisals); and varieties of patient appraisals and clinicians' preceding and following utterances. METHODS: Two coders rated videotaped initial visits of 25 early-stage prostate cancerpatients to their radiation oncologist. SDM skills were assessed using the Decision Analysis System for Oncology (DAS-O); appraisals and clinicians' utterances were labeled using qualitative methodology. RESULTS: Clinicians offered a treatment choice to 10 patients. They informed 15/25 about pros and 20/25 about cons of options. Patients expressed 67 appraisals (median/visit=2; range, 0-12). Half of appraisals were favorable and one-fourth was unfavorable toward treatment options. One-fifth referred to explicit tradeoffs. One-third of appraisals followed clinician requests; 58% followed clinician information. Clinicians approved almost half of appraisals. They contested, ignored or highlighted a minority. CONCLUSION: Clinicians infrequently offered patients a choice or explored appraisals. Most appraisals supported rather than challenged treatment options. Clinicians most often legitimized appraisals, thereby helping patients to feel good about the decision. Exploring appraisals may help patients in forming more stable preferences, thus benefiting patients in the long run. PRACTICE IMPLICATION: Clinicians should request patient appraisals and ascertain whether these seem well-informed before making treatment recommendations.
Authors: Inge Henselmans; Hanneke W M van Laarhoven; Hanneke C J M de Haes; Meltem Tokat; Ellen G Engelhardt; Pomme E A van Maarschalkerweerd; Marleen Kunneman; Petronella B Ottevanger; Serge E Dohmen; Geert-Jan Creemers; Dirkje W Sommeijer; Filip Y F L de Vos; Ellen M A Smets Journal: Oncologist Date: 2018-06-29
Authors: Stephen G Henry; Danielle Czarnecki; Valerie C Kahn; Wen-Ying Sylvia Chou; Angela Fagerlin; Peter A Ubel; David R Rovner; Stewart C Alexander; Sara J Knight; Margaret Holmes-Rovner Journal: Health Expect Date: 2013-12-22 Impact factor: 3.377
Authors: Nadiyah Sulayman; Elizabeth Spellman; Kristi D Graves; Beth N Peshkin; Claudine Isaacs; Marc D Schwartz; Suzanne C O'Neill Journal: J Cancer Epidemiol Date: 2012-07-30
Authors: Inge Spronk; Maartje C Meijers; Marianne J Heins; Anneke L Francke; Glyn Elwyn; Anne van Lindert; Sandra van Dulmen; Liesbeth M van Vliet Journal: Eur J Cancer Care (Engl) Date: 2019-05-08 Impact factor: 2.328
Authors: Haske van Veenendaal; Loes J Peters; Dirk T Ubbink; Fabienne E Stubenrouch; Anne M Stiggelbout; Paul Lp Brand; Gerard Vreugdenhil; Carina Gjm Hilders Journal: JMIR Res Protoc Date: 2022-04-06
Authors: N C A van der Velden; M B A van der Kleij; V Lehmann; E M A Smets; J M L Stouthard; I Henselmans; M A Hillen Journal: Int J Environ Res Public Health Date: 2021-05-26 Impact factor: 3.390
Authors: Linda Brom; Janine C De Snoo-Trimp; Bregje D Onwuteaka-Philipsen; Guy A M Widdershoven; Anne M Stiggelbout; H Roeline W Pasman Journal: Health Expect Date: 2015-12-16 Impact factor: 3.377